GNLX today
$1.88-$0.07 (-3.59%)close Nov 11, 2026Trend
DailyDowntrend (confirmed)
4 hourStrong Bearish
1 hourSymmetric Triangle
15 minDescending Triangle
5 minStrong Bearish
Daily trend turns up above $2.27
Key levels
Resistance$2.32
Resistance$2.10
Support$1.77
Latest news & SEC filings
SEC FilingGENELUX Corp filed an insider trading report (Form 4)
ProductGenelux notes published case report on Olvi-Vec with platinum rechallenge
All GNLX news →About Genelux
Genelux is a clinical-stage biopharmaceutical company developing oncolytic viral immunotherapies for aggressive and hard-to-treat cancers. Its lead candidate, Olvi-Vec, is an engineered vaccinia virus intended to destroy cancer cells while provoking an immune response, and is being tested in ovarian, non-small cell lung, and small cell lung cancers. The company runs a manufacturing site in San Diego, California, and has licensed rights to Olvi-Vec in China to Newsoara.
Based on the company's 10-K filed Mar 19, 2026.
Nasdaq · Healthcare
GENELUX Corp (GNLX)
What Is the Price Target for GNLX?
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Is GNLX a Buy or Sell Right Now?
Thesis
- •Revenue growing 0.0% YoY with UNKNOWN trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for GNLX.
Start Free Trial →Is GNLX Overvalued or Undervalued?
Valuation Verdict
OVERVALUED
Methods Used
P/B
Fair Value
$0.88
12
Moat Score
NONE
2/9
Piotroski Score
-19.9
Altman Z-Score
What Is Smart Money Doing with GNLX?
Insider Signal
SELLING
0 buys / 15 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Cappello Joseph | officer | Sale | 668 | $1K | Nov 3, 2026 |
| Zindrick Thomas | officer | Sale | 3,089 | $6K | Nov 3, 2026 |
| Yu Yong | officer | Sale | 668 | $1K | Nov 3, 2026 |
| Cappello Joseph | officer | Sale | 10,257 | $28K | Aug 31, 2026 |
| Zindrick Thomas | officer | Sale | 34,463 | $92K | Aug 31, 2026 |
| Yu Yong | officer | Sale | 9,683 | $27K | Aug 31, 2026 |
| Smalling Ralph | officer | Sale | 192 | $562.56 | Jun 3, 2026 |
| Thomas John | director | Sale | 10,000 | $30K | Jun 1, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →GNLX Growth Story
Revenue YoY
0.0%
3yr Revenue CAGR
N/A%
EPS Growth YoY
9.47%
FCF Growth YoY
-22.0%
Revenue Trend
UNKNOWN
Dark Pool Trades for GNLX
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for GNLX, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 20:36:56 | $1.91 | 1,600 | $$3K | BUY |
| 20:22:08 | $1.90 | 9,900 | $$19K | SELL |
| 19:59:20 | $1.86 | 1,672 | $$3K | SELL |
| 19:59:20 | $1.87 | 1,672 | $$3K | SELL |
| 19:40:35 | $1.87 | 1,900 | $$4K | MIDPOINT |
5 dark pool trades shown · $$32K preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for GNLX
PREVIEWSEPT Investing provides real-time options flow tracking for GNLX, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $2.5 | Dec 18 | 37 | $$60 | 1 | SWEEP |
| CALL | $2.5 | Dec 18 | 37 | $$60 | 1 | SWEEP |
| CALL | $2.5 | Dec 18 | 37 | $$120 | 2 | SWEEP |
| CALL | $2.5 | Dec 18 | 37 | $$60 | 1 | SWEEP |
| CALL | $2.5 | Dec 18 | 37 | $$60 | 1 | SWEEP |
5 options trades shown · 100% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for GENELUX Corp (GNLX) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →GNLX — frequently asked questions
What is GNLX stock price today?
GENELUX Corp (GNLX) is at $1.88, down 3.59% (-$0.07) at the Nov 11, 2026 close.
Why is GNLX stock moving today?
Latest GNLX news — Nov 5, 2026: GENELUX Corp filed an insider trading report (Form 4) · Sep 9, 2026: Genelux notes published case report on Olvi-Vec with platinum rechallenge
What do analysts rate GNLX?
Analyst ratings for GNLX: 6 Buy, 0 Hold, 0 Sell — consensus Strong Buy.
Did GNLX beat earnings?
GNLX last reported on Aug 13, 2026: EPS -$0.21 vs -$0.20 expected — a miss of 6.8%.
Does GNLX pay a dividend?
GNLX does not currently pay a dividend.
What are GNLX support and resistance levels?
Support: $1.77. Resistance: $2.10, $2.32, $2.61.
What are insiders doing with GNLX?
Insider activity: SELLING, 0 buys and 15 sells in the last 90 days.
What is the latest news on GNLX?
Nov 5, 2026: GENELUX Corp filed an insider trading report (Form 4) · Sep 9, 2026: Genelux notes published case report on Olvi-Vec with platinum rechallenge